We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ICBP:IDXPT Indofood CBP Sukses Makmur Tbk Analysis

Data as of 2026-08-08 - not real-time

IDR 7,750.00

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

PT Indofood CBP Sukses Makmur Tbk is priced at IDR 7,750.00, and its moving averages give no clean directional read — the structure is neutral. It has gained 17.4% over the past 30 days. Momentum indicators put RSI at 77.2 (overbought) with MACD reading bullish. The recent range runs from support at IDR 6,575.00 up to resistance at IDR 7,750.00.
Valuation screens as undervalued, on a P/E of 12.2 with no clean sector comparison available. Analyst price targets sit 21.0% above the current price. Revenue is growing at 15.7% on a 9.3% profit margin. The 3.42% dividend yield looks covered by current payout levels.
Risk comes out at 4 of a possible 10, a moderate reading. With 30-day volatility of 24.5%, a beta of 0.30 and a maximum drawdown of 40.0%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to buy, carrying 6/10 conviction.

Top Market Events

KONTAN.CO.ID – JAKARTA. PT Indofood CBP Sukses Makmur Tbk ICBP mencatat penurunan laba bersih pada kuartal I –...Hosted on MSN1monIndofood CBP ICBP bakal bagi dividen Rp 265 per sahamKONTAN.Hosted on MSN1monCum dividen tiba, saham grup Salim ini mengandung dividen Rp 26.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 5/10

Key Factors

  • RSI at 77.2 signals overbought conditions
  • Trading above the 200-day average of 7609.00
  • MACD momentum is positive

Medium Term

1–3 years
Positive
Model confidence: 5/10

Key Factors

  • RSI at 77.2 signals overbought conditions
  • Trading above the 200-day average of 7609.00
  • Analyst targets imply +21.0% versus the current price

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Analyst targets imply +21.0% versus the current price
  • Revenue growth of +15.7%
  • P/E ratio of 12.2

Key Metrics & Analysis

Financial Health

Revenue Growth15.70%
Profit Margin9.34%
P/E Ratio12.2
ROE12.55%
ROA7.31%
Debt/Equity66.65
P/B Ratio1.7
Op. Cash FlowIDR12933.2B
Free Cash FlowIDR7778.5B

Technical Analysis

TrendNeutral
RSI77.2
SupportIDR 6,575.00
ResistanceIDR 7,750.00
MA 20IDR 7,011.25
MA 50IDR 6,777.50
MA 200IDR 7,609.00
MACDBullish
VolumeIncreasing
Fear & Greed Index94.82

Valuation

Fair ValueIDR 15,134.85
Target PriceIDR 9,378.00
Upside/Downside21.01%
GradeUndervalued
TypeBlend
Dividend Yield3.42%

Risk Assessment

Beta0.30
Volatility24.51%
Sector RiskLow
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.